Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
View ORCID ProfileHeather Marriott, View ORCID ProfileThomas P. Spargo, View ORCID ProfileAhmad Al Khleifat, View ORCID ProfileIsabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, View ORCID ProfileJohnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, View ORCID ProfileMamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, View ORCID ProfileVincenzo Silani, Nicola Ticozzi, View ORCID ProfilePhilip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, View ORCID ProfileJan H. Veldink, Richard J. Dobson, Patrick Schwab, View ORCID ProfileAmmar Al-Chalabi, Alfredo Iacoangeli
doi: https://doi.org/10.1101/2022.11.03.22281905
Heather Marriott
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
Thomas P. Spargo
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
Ahmad Al Khleifat
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
Isabella Fogh
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
Peter M Andersen
3Department of Clinical Science, Umeå University, Umeå SE-901 85, Sweden
Nazli A. Başak
4Koc University, School of Medicine, Translational Medicine Research Center, NDAL, Istanbul, 34450, Turkey
Johnathan Cooper-Knock
5Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
Philippe Corcia
6UMR 1253, Université de Tours, Inserm, Tours 37044, France
7Centre de référence sur la SLA, CHU de Tours, Tours 37044, France
Philippe Couratier
8Centre de référence sur la SLA, CHRU de Limoges, Limoges, France
9UMR 1094, Université de Limoges, Inserm, Limoges 87025, France
Mamede de Carvalho
10Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
Vivian Drory
11Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv 64239, Israel
12Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel
Jonathan D. Glass
13Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, GA 30322, USA
Marc Gotkine
14Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel
15Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel
Orla Hardiman
16Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
John E. Landers
17Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA
Russell McLaughlin
18Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
Jesús S. Mora Pardina
19ALS Unit, Hospital San Rafael, Madrid, Spain
Karen E. Morrison
20School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7BL, UK
Susana Pinto
10Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
Monica Povedano
21Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona 08907, Spain
Christopher E. Shaw
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
Pamela J. Shaw
5Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
Vincenzo Silani
22Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
23Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122
Nicola Ticozzi
22Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
23Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122
Philip van Damme
24University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium
25VIB, Center for Brain and Disease Research, Leuven, Belgium & Neuroscience Department, Leuven Brain Institute, KU Leuven, Belgium
Leonard H. van den Berg
26Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
Patrick Vourc’h
6UMR 1253, Université de Tours, Inserm, Tours 37044, France
27Service de Biochimie et Biologie molécularie, CHU de Tours, Tours 37044, France
Markus Weber
28Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
Jan H. Veldink
26Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
Richard J. Dobson
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
29NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, UK
30Institute of Health Informatics, University College London, London, NW1 2DA, UK
31NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, UK
Patrick Schwab
32GlaxoSmithKline, Artificial Intelligence and Machine Learning
Ammar Al-Chalabi
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
33King’s College Hospital, London, SE5 9RS, UK
Alfredo Iacoangeli
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
29NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, UK
Article usage
Posted November 05, 2022.
Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
Heather Marriott, Thomas P. Spargo, Ahmad Al Khleifat, Isabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Richard J. Dobson, Patrick Schwab, Ammar Al-Chalabi, Alfredo Iacoangeli
medRxiv 2022.11.03.22281905; doi: https://doi.org/10.1101/2022.11.03.22281905
Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
Heather Marriott, Thomas P. Spargo, Ahmad Al Khleifat, Isabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Richard J. Dobson, Patrick Schwab, Ammar Al-Chalabi, Alfredo Iacoangeli
medRxiv 2022.11.03.22281905; doi: https://doi.org/10.1101/2022.11.03.22281905
Subject Area
Subject Areas
- Addiction Medicine (242)
- Allergy and Immunology (524)
- Anesthesia (125)
- Cardiovascular Medicine (1430)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10320)
- Gastroenterology (532)
- Genetic and Genomic Medicine (2645)
- Geriatric Medicine (255)
- Health Economics (499)
- Health Informatics (1743)
- Health Policy (791)
- Hematology (269)
- HIV/AIDS (569)
- Medical Education (274)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2475)
- Nursing (145)
- Nutrition (380)
- Oncology (1330)
- Ophthalmology (403)
- Orthopedics (151)
- Otolaryngology (238)
- Pain Medicine (172)
- Palliative Medicine (51)
- Pathology (343)
- Pediatrics (784)
- Primary Care Research (296)
- Public and Global Health (5024)
- Radiology and Imaging (898)
- Respiratory Medicine (686)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (299)
- Toxicology (45)
- Transplantation (141)
- Urology (108)